Evaluating MELCARE, a nurse-led survivorship program
A recent MELCARE pilot study assessed the feasibility, acceptability and benefits of a nurse-led survivorship program for people with metastatic melanoma.
Community Fundraising Wrap Up Jan-June 2022
Read about the creative ways our wonderful community fundraisers have been raising funds to support MIA to reach zero deaths from melanoma.
MIA’s Prof Georgina Long AO named as world’s top melanoma expert
Prof Long has been named No 1 Melanoma Expert in worldwide rankings just released by expertscape, based on articles published 2012-2022.
We had a ball at the Amie St Clair Annual Ball!
After a two year COVID-delay, close to 300 people enjoyed a fun-filled 10th anniversary celebration at the MIA Amie St Clair Ball.
MIA launches world-first tool to predict immunotherapy response
New clinical tool developed by Melanoma Institute Australia hailed a breakthrough in personalising treatment for all cancer patients.
Skin Cancer Tasmania merges with Melanoma Institute Australia
Tasmanian skin cancer patients to benefit from increased prevention and awareness campaigns, and bolstered melanoma support services.
MIA researchers showcase new frontier in melanoma treatment at ASCO 2022
An unprecedented number of breakthroughs to be presented by MIA researchers at world's leading clinical oncology conference.
Thank you to everyone involved in Melanoma March 2022
A message of thanks from Matthew Browne, Melanoma Institute Australia CEO, to everyone involved in Melanoma March. Funds raised allow our Personalised Immunotherapy Platform (PIP) Clinical Trial to commence.
A melanoma message from NRL legend Ray Price and his wife Sandy
The pair, who have both been diagnosed with melanoma, are keen to raise funds and awareness for melanoma and will be participating in Melanoma March Coolangatta.
Global breakthrough in stopping melanoma spreading around body
Immunotherapy after surgery proven effective in reducing disease spread in high risk early stage patients.